Distributional cost-effectiveness analysis
Distributional cost-effectiveness analysis (DCEA) is an extension of cost-effectiveness analysis (CEA) that incorporates concern for both the average levels of outcomes as well as the distribution of outcomes. It is particularly useful when evaluating interventions to tackle health inequality.[1][2]
DCEA includes Extended Cost Effectiveness Analysis, which in addition to standard CEA assesses the costs and effectiveness for different socioeconomic groups.[3]
References
[edit]- ^ Asaria, M; Griffin, S; Cookson, R; Whyte, S; Tappenden, P (June 2015). "Distributional cost-effectiveness analysis of health care programmes--a methodological case study of the UK Bowel Cancer Screening Programme" (PDF). Health Economics. 24 (6): 742–54. doi:10.1002/hec.3058. PMID 24798212.
- ^ Asaria, M; Griffin, S; Cookson, R (January 2016). "Distributional Cost-Effectiveness Analysis: A Tutorial". Medical Decision Making. 36 (1): 8–19. doi:10.1177/0272989x15583266. PMC 4853814. PMID 25908564.
- ^ Verguet, Stéphane; Kim, Jane J.; Jamison, Dean T. (2016). "Extended Cost-Effectiveness Analysis for Health Policy Assessment: A Tutorial". Pharmacoeconomics. 34 (9): 913–923. doi:10.1007/s40273-016-0414-z. ISSN 1170-7690. PMC 4980400. PMID 27374172.
 | This accounting-related article is a stub. You can help Wikipedia by expanding it. |
 | This health-related article is a stub. You can help Wikipedia by expanding it. |